NasdaqCM - Delayed Quote • USD
Windtree Therapeutics, Inc. (WINT)
At close: April 25 at 4:00 PM EDT
After hours: April 25 at 7:58 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | -- | -- | 1 | 1 |
Avg. Estimate | 0 | 0 | -0.97 | -0.66 |
Low Estimate | 0 | 0 | -0.97 | -0.66 |
High Estimate | 0 | 0 | -0.97 | -0.66 |
Year Ago EPS | -4.76 | -1.64 | -5.24 | -0.97 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 1 | 1 |
Avg. Estimate | -- | -- | -- | 12.2M |
Low Estimate | -- | -- | -- | 12.2M |
High Estimate | -- | -- | -- | 12.2M |
Year Ago Sales | -- | -- | -- | -- |
Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | -0.56 | -0.68 | -0.63 | -0.94 |
EPS Actual | -4.76 | -1.64 | -0.86 | -0.74 |
Difference | -4.2 | -0.96 | -0.23 | 0.2 |
Surprise % | -750.00% | -141.20% | -36.50% | 21.30% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0 | 0 | -0.97 | -0.66 |
7 Days Ago | -0.55 | -0.54 | -0.97 | -0.66 |
30 Days Ago | -0.55 | -0.54 | -0.97 | -0.66 |
60 Days Ago | -0.55 | -0.54 | -0.97 | -0.66 |
90 Days Ago | -0.55 | -0.54 | -0.97 | -0.66 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | WINT | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -- | -- | -- | 2.60% |
Next Qtr. | -- | -- | -- | 13.40% |
Current Year | 81.50% | -- | -- | 5.20% |
Next Year | 32.00% | -- | -- | 13.30% |
Next 5 Years (per annum) | -- | -- | -- | 11.11% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Initiated | HC Wainwright & Co.: Neutral | 1/3/2024 |
Related Tickers
BPTS Biophytis S.A.
8.22
-13.47%
PIRS Pieris Pharmaceuticals, Inc.
11.60
-2.85%
ALLR Allarity Therapeutics, Inc.
1.4300
+4.38%
ATXI Avenue Therapeutics, Inc.
0.1170
+24.07%
ZVSA ZyVersa Therapeutics, Inc.
0.6075
-0.41%
HEPA Hepion Pharmaceuticals, Inc.
1.2900
-2.27%
ABVC ABVC BioPharma, Inc.
1.5900
+7.43%
FNCH Finch Therapeutics Group, Inc.
2.2400
-2.18%
RNAZ TransCode Therapeutics, Inc.
0.5250
+19.35%
APVO Aptevo Therapeutics Inc.
0.6800
-0.38%